Table 4.
Marker | Normal | IGR | T2DM | F-value | P-value | F-value adjusted for serum Cr, age, BMI | P-value adjusted for serum Cr, age, BMI |
---|---|---|---|---|---|---|---|
| |||||||
Ca, mmol/L | 2.36±0.08 | 2.35±0.09 | 2.36±0.09 | 5.18 | 0.00 | 3.52 | 0.03 |
P, mmol/L | 1.09±0.15 | 1.08±0.14 | 1.1±0.15 | 2.89 | 0.06 | 3.94 | 0.02 |
ALP, U/L | 63.85±17.70 | 62.83±16.22 | 63.14±17.59 | 1.31 | 0.27 | 1.51 | 0.23 |
25(OH)D, ng/mL | 20.36±8.94 | 21.82±9.30 | 22.49±10.14 | 5.33 | 0.00 | 4.63 | 0.01 |
PTH, pg/mL | 38.10±14.36 | 41.09±15.97 | 39.17±15.27 | 8.21 | 0.00 | 1.72 | 0.18 |
β-CTX, ng/mL | 0.30±0.15 | 0.29±0.16 | 0.26±0.16 | 6.40 | 0.00 | 3.84 | 0.02 |
BGP, ng/mL | 18.25±8.32 | 16.56±7.85 | 15.05±7.03 | 5.34 | 0.00 | 7.75 | 0.00 |
P1NP, ng/mL | 38.12±14.28 | 35.85±17.45 | 34.09±22.12 | 10.24 | 0.00 | 3.79 | 0.02 |
Notes: Values are presented as mean ± SD. ANOVA was used for analysis.
Abbreviations: BGP, bone gamma-carboxyglutamic acid protein (osteocalcin); BMI, body mass index; Ca, calcium; Cr, creatinine; β-CTX, β-carboxy-terminal cross-linking telopeptide of type I collagen; 25(OH)D, 25-hydroxyvitamin D; IGR, impaired glucose regulation; P, phosphorus; P1NP, procollagen type 1 intact N-terminal propeptide; PTH, parathyroid hormone; T2DM, type 2 diabetes mellitus.